Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Design of a Predictive Model of Mortality in Critically Ill Patients Colonized by Multiresistant Gram-negative Bacteria. MR-GEIPC STUDY

NCT07749508 is registered in ClinicalTrials.gov with Fundacion SEIMC-GESIDA as lead sponsor.

NCT NCT07749508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07749508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Design of a Predictive Model of Mortality in Critically Ill Patients Colonized by Multiresistant Gram-negative Bacteria. MR-GEIPC STUDY
Lead sponsor
Fundacion SEIMC-GESIDA
Phase
Observational
Overall status
Recruiting
Start date
March 2, 2026
Completion date
May 31, 2027
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multi-resistant gram-negative bacteria cause infection